PATENT CLAIM ANALYSIS

Application Number: 15939831
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "294000"]

Abstract:
This invention relates to pharmaceutical compositions containing (+)-β-dihydrotetrabenazine and their therapeutic uses, in particular in their use in the treatment of movement disorders, such as Tourette's syndrome.

Claim (Index 10):
A method according to  claim 7  wherein the method comprises administering to a subject an amount of (+)-\u03b2-dihydrotetrabenazine from 1 mg/kg to 10 mg/kg (e.g. between 1 mg/kg and 10 mg/kg) per day.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.13333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15939837', '15939826', '12555695', '13237709', '15044655']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7839304801761176
- 35 USC 102 Novelty (BERT): 0.550191270101802
- Combined Prediction Score: 0.760556559168686
- Mean Citation Score: 306.810936
- Max Citation Score: 411.52753
- Similarity Product: 271.86011746120573

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test